Home
/
Lambda Insights
/
Lambda Resource Center

Lambda Resource Center

Services & Capabilities

Bioanalytical Methods / Assay List (Lambda & Novum)

Blog

Study Insights: Phase-I, Bioequivalence Study of Trastuzumab SC Injection

Blog

Specialized Clinical Development Support for Semaglutide Programs

News

Bioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s

News

Lambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year

Clinical Research Update

Clinical Research Update – June 2025

BlogClinical Research

Full-Service CRO | End-to-End Expertise for Every Phase of Clinical Development

Clinical Research Update

Clinical Research Update – May 2025

Case-Study

Insights: Bioequivalence Study of Semaglutide Injection

BlogLabs

Study Insights: Bioequivalence Study of Semaglutide Injection 1.34 mg/ml (2 mg/1.5 mL)

BlogLate Phase

Ovarian Cancer Clinical Trials – Advancing Research Through Patient-Focused Approaches

News

Lambda Ahmedabad Successfully Completes USFDA Inspection without any 483 Observations

Early PhaseServices & Capabilities

End-to-End BA BE Studies Expertise

BiosimilarServices & Capabilities

End-to-end Biosimilar Development and Clinical Trials Expertise

Late PhaseServices & Capabilities

Advancing Late Phase Clinical Trials

Clinical Research Update

Clinical Research Update – April 2025

BlogLate Phase

Strategic Endpoint Selection for Successful Oncology Clinical Trials

BlogClinical Research

Navigating CDSCO Regulations: Key Approval Processes and Lambda’s Regulatory Support

News

USFDA Approves ANDA for Protein-Bound Paclitaxel Injection: Program supported by Lambda as the key Bioanalytical Partner

BlogLate Phase

Advancing Clinical Development in Women’s Health

BlogLabs

A Highly Precise, Accurate, and Robust LC-MS/MS Method for the Quantification of Semaglutide in Human Plasma

News

Lambda Successfully Completes Multi-Site EMA Inspection for Biosimilar Product

Clinical Research Update

Clinical Research Update – March 2025

News

Lambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services

Clinical Research Update

Clinical Research Update – February 2025

News

Successful completion of the Ministry of Health inspection of the Republic of Kazakhstan (October 2024)

BlogLate Phase

Patient-Centric Trials in Advancing Cancer Research: A Journey of Progress & Hope

BlogPharmacovigilance

Ensuring Drug Safety: Lambda’s Pharmacovigilance Milestones in 2024

Clinical Research Update

Clinical Research Update – January 2025

News

Lambda Excels in US FDA Inspection for PV with Zero Findings – 3rd Success in 2024

BlogEarly Phase

Nutraceuticals and Consumer Products Studies: Ensure product safety & efficacy with expert-led trials

BlogLate Phase

Advancing Prostate Cancer Clinical Trials: Key Insights

Clinical Research Update

Clinical Research Update – Lambda Newsletter – December 2024

BlogLabs

Summation of Similar Product Ions for Improved LC-MS-MS Quantitation: Advancing Peptide Analysis

BlogClinical Research

What are Clinical Trials? Unlocking the Basics and the Critical Importance

Clinical Research Update

Understanding Clinical Trials: A Beginner’s Guide to Clinical Research

BlogLate Phase

Advancing Lung Cancer Clinical Trials

BlogPharmacovigilance

Efficient ICSR Management and Regulatory Compliance for Bulk Case Handling

BlogLate Phase

Breast Cancer Clinical Trials – Transforming Lives Through Patient-Centric Trials

Clinical Research Update

Addressing Top Clinical Research FAQs for Pharma and Biotech

Let's Unveil New Therapies Together

Connect with our experts to leverage our proven track record of clinical research excellence.